However, research suggests that in IBD, the upregulation of IL-21 disrupts multiple metabolic pathways, including oxidative phosphorylation (OXPHOS) and glycolysis, thus leading to disturbances in the structure of the mitochondria-endoplasmic reticulum (ER) network (80). This evidence concerns the gene IL21 and inflammatory bowel disease.